Effectiveness of 3rd generation cephalosporin compare to 3rd generation cephalosporin - macrolides for community acquired pneumonia patients in PKU Muhammadiyah Yogyakarta Hospital
DOI:
https://doi.org/10.12928/pharmaciana.v9i2.10068Keywords:
antibiotics, therapy effectiveness, Community Acquired Pneumonia (CAP)Abstract
Pneumonia is a lung infection caused by bacteria with high fever symptoms accompanied by cough with phlegm, shortness of breath. According to Riskesdas 2013 results, the prevalence of pneumonia based on diagnosis at Yogyakarta Special Region is 1.7% and 4.6%. The researcher has founds 172 adult patients diagnosed pneumonia during 2011-2016 in PKU Muhammadiyah Yogyakarta hospital. This study aims to determine the level of effectiveness between 3rd generation cephalosporins with 3rd generation cephalosporins and macrolides on the outcome of adult patients with pneumonia in PKU Muhammadiyah Yogyakarta hospital period 2015-2017. It was a retrospective cohort study with an affordable population. There were two groups of 3rd generation cephalosporins (n = 24) compared to the 3rd generation cephalosporins and macrolide (n = 13) measured results in the form of body temperature, shortness of breath, leukocyte count, and length of hospitalization using univariate and bivariate analyzes. Based on the results of the study, 70.3% was dominated by men, and 51.4% was dominated by the age group > 59 years. Both of groups showed a significant difference to the temperature where p=0.001 with difference of temperature decrease 0.79 ± 1.06 oC for single group while p=0.049 with difference of temperature decrease 0.65 ± 1.07 oC for combination group; as well as against leukocyte, both of groups had a value of p=0.001 where difference of leucocyte decrease was 4.80 ± 3.92 103/mm3 for single group and 5.43 ± 4.27 103 / mm3 combination group. While both of group showed no significant difference for shortness of breath p=0.638 with OR (95% CI) 2.4 (0.23 – 24.06) and p=0.435 for hospitalization, in single group was 5.88 ± 3.261 days while in combination group was 5.00 ± 1.826, this shows that the combination group had an average length of hospitalization of 0.88 days faster than the single group. The effectiveness between two groups showed a significant difference with p<0.05 on body temperature and leukocyte count. While both groups did not show a significant difference with p>0.05 to shortness of breath and length of stay.References
Anonim., 2013, Riset Kesehatan Dasar, hal: 67, Kementrian Kesehatan Republik Indonesia, Jakarta. Diakses 17 November 2016.
Baratawidjaja, K. G., Rengganis, I., 2014, Imunologi Dasar edisi ke-11 (cetakan ke-2), Fakultas Kedokteran Universitas Indonesia: Jakarta.
Bradley, J.S., Byington, C.L., Shah, S.S., Alverson, B.I., Carter, E.R., Harrison, C., et al., 2011, Executive Summary: The Management of Community-Acquired Pneumonia In Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by The Paediatric Infection Diseases Society and The Infectious Diseases Society of America. Clinical Infectious Diseases: An Official Publication of The Infectious Diseases Society of America, 53:617-630.
Caballero, J., and Rello, J., 2011, Combination antibiotic therapy for community-acquired pneumonia, Annals of Intensive Care a Springer Open Journal, 1:48.
Culić O, Eraković V, Cepelak I, Barisić K, Brajsa K, Ferencić Z, Galović R, et al., 2002, Azithromycin Modulates Neutrophil Function And Circulating Inflammatory Mediators In Healthy Human Subjects, European journal of pharmacology, 450(3) :277–289.
Elfidasari, D., Noriko, N., Mirasaraswati, A., Feroza, A., dan Canadianti, S. F., 2013, Deteksi bakteri Klabsiella pneumoniae pada beberapa jenis rokok konsumsi masyarakat, Jurnal Al-Azhar Indonesia Seri Sains dan Teknologi, 2: (1): 41-47.
Hariri, Geoffroy., Tankovic, C., Boelle, P.Y., Dubee, V., Leblanc, G., Pichereau, C., Bourcier, S., Bige, N., Baudel, J.L., Galbois, A., Ait_Oufella, H., and Maury, E, 2017, Are Third-Generation Cephalosporins Unavoidable For Empirical Therapy Of Community-Acquired Pneumonia In Adult Patients Who Require ICU Admission? A Retrospective Study, Annals of Intensive Care, 7(1): 35.
Ontario, H. Q., 2013, Monotherapy Versus Combination Therapy for Adults Hospitalized for Community-Acquired Pneumonia : A Rapid Review, November: 1–21.
Kamal, A.M., 2015, Evaluasi Penggunaan Antibiotik Pada Pasien Pneumonia di RSUD Sukoharjo 2014, Naskah Publikasi, UMS.
Niet W., Bing Lit, and Qingyu Xiu., 2014, B-Lactam/Macrolide Dual Therapy Versus B-Lactam Monotherapy For The Treatment Of Community-Acquired Pneumonia In Adults: A Systematic Review And Meta-Analysis, Journal of Antimicrobial Chemotherapy, 69(6): 1441-1446.
Pahriyani, A., Khotimah, N., Bakar, L., 2015, Evaluasi Penggunaan Antibiotik pada Pasien Community Acquired Pneumonia (CAP) di RSUD Budi Asih Jakarta Timur, Farmasains, 2 (6): 259-263.
Prince, Sylvia Anderson, Wilson, Lorraine MC Carty, 2006, Patofisiologi Konsep Klinis Proses-proses Penyakit ed. 6 Vol. 1, Terjemahan: Brahm U. Penerbit Buku Kedokteran EGC, Jakarta: 105.
Said, M., 2010,Pneumonia Anak Balita dalam Rangka Pencapaian, Jakarta: MDG 4.
Sajinadiyasa I. GK., Ngurah-Rai IB., Sriyeni LG., 2011, Perbandingan Antara Pemberian Antibiotik Monoterapi dengan Dualterapi Terhadap Outcome pada Pasien Community-acquired Pneumonia (CAP) di Rumah Sakit Sanglah Denpasar, Journal Penyakit Dalam, 12(1): 13-20.
Takizawa H, Desaki M, Ohtoshi T, Kawasaki S, Kohyama T, Sato M, Tanaka M, Kasama T, Kobayashi K, Nakajima J, Ito K., 1997, Erythromycin modulates IL-8 expression in normal and
Pharmaciana ISSN: 2088 4559; e-ISSN: 2477 0256
Effectiveness of Single …(Suprobo et al.,)
inflamed human bronchial epithelial cells. American Journal of Respiratory and Critical Care Medicine,156(1):266-271.
Trowbridge, J. F., M. D., Richard J. Artymowicz, PharmD, BCPS, Claire E. Lee, RN, MSN, Patricia D. Brown, MD, Margo S. Farber, PharmD, William Kernan, PharmD, James E. Beaulieu, PharmD, Morton P. Goldman, PharmD, Fran Yanak, BSN, RN, James S. Lewis II, PharmD, K. P. Ravikrishnan, MD, FRCP (C), William Krebs, PhD, David Day, PhD, and Teresa J. Lubowski, PharmD., 2002, Antimicrobial selection and length of hospitasl stay in patients with community-acquired pneumonia, JCOM, 9 (11) : 613-619.
Nie, W., Li, B., and Xiu, Q., 2014, β-Lactam/macrolide dual therapy versus β-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy, 69(6):1441–1446.
National Institute For Health And Clinical Excellence (NICE)., 2014, Pneumonia In Adults: Diagnosis And Management, Clinical guideline CG191, (December): 1–26.
Woodhead, M., Sani A., Corrine A., et al., 2014, National Institute for Health and Care Excellence: Pneumonia in aduults: diagnosis and management, Clinical guideline: Pusblished: 3 Desember 2014.
Zhong, N.S., Sun T, Zhuo C., D'Souza G., Lee S.H., Lan N.H., Chiang C.H., Wilson D., Sun F., Iaconis J., Melnick D., 2015, Ceftaroline Fosamil Versus Ceftriaxone For The Treatment Of Asian Patients With Community-Acquired Pneumonia: A Randomised, Controlled, Double-Blind, Phase 3, Non-Inferiority With Nested Superiority Trial, The Lancet Infectious Diseases, 15(2) :161–171
Downloads
Published
Issue
Section
License
Authors who publish with Pharmaciana agree to the following terms:
- Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
1.png)
